Werba Rubin Papier Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Werba Rubin Papier Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378K	Hold	1,986	–	–	0.05%	180
2026 Q1	$335K	Sell	1,986 -956	-32%	-$163K	0.05%	181
2025 Q4	$496K	Buy	2,942 +2	+0.1%	+$325	0.13%	112
2025 Q3	$425K	Hold	2,940	–	–	0.07%	132
2025 Q2	$372K	Buy	2,940 +20	+0.7%	+$2.46K	0.07%	134
2025 Q1	$373K	Buy	2,920 +1	+0%	+$136	0.08%	120
2024 Q4	$386K	Buy	2,919 +1	+0%	+$141	0.09%	118
2024 Q3	$425K	Buy	2,918 +76	+3%	+$11K	0.1%	113
2024 Q2	$390K	Buy	2,842 +877	+45%	+$117K	0.11%	105
2024 Q1	$270K	Hold	1,965	–	–	0.08%	114
2023 Q4	$267K	Hold	1,965	–	–	0.09%	90
2023 Q3	$241K	Hold	1,965	–	–	0.09%	99
2023 Q2	$249K	Hold	1,965	–	–	0.09%	97
2023 Q1	$254K	Hold	1,965	–	–	0.1%	83
2022 Q4	$258K	Buy	+1,965	New	+$254K	0.11%	83

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Werba Rubin Papier Wealth Management's IBB Position: Q2 2026 in Review

Werba Rubin Papier Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,986 shares worth $378K. The position accounts for 0.05% of the portfolio, ranked #180.

Werba Rubin Papier Wealth Management first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. The position peaked at $496K in Q4 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Werba Rubin Papier Wealth Management held 1,986 shares of iShares Biotechnology ETF worth $378K as of Q2 2026.
Werba Rubin Papier Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.05% of Werba Rubin Papier Wealth Management's portfolio in Q2 2026, its #180 holding.
Werba Rubin Papier Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
Werba Rubin Papier Wealth Management's iShares Biotechnology ETF position peaked at $496K in Q4 2025.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Werba Rubin Papier Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.